ERBB2 and neoplasm: In a classification spectrum of 400 TNBC tumor patients, it was found that 72% were classified as basal-like, 9% were classified as HER2-enriched, 6% were classified as luminal B, 5% were classified as luminal A, and 8% were classified as normal breast-like [100].